Modelling neurodegeneration in prion disease – applications for drug development

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.2, Iss.6, 2007-06, pp. : 777-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNAi for the Treatment of Prion Disease: A Window for Intervention in Neurodegeneration?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 5, 2009-11 ,pp. : 342-352

Bentham Science Publishers

Access to resources Recommend Favorite

The Cell Cycle Molecules Behind Neurodegeneration in Alzheimer's Disease: Perspectives for Drug Development

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2420-2432

Bentham Science Publishers

Access to resources Recommend Favorite

Modelling during drug development

By Balant L.P. Gex-Fabry M.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 13-26

Elsevier

Access to resources Recommend Favorite

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

Current Cancer Drug Targets, Vol. 13, Iss. 8, 2013-10 ,pp. : 895-904

Bentham Science Publishers

Access to resources Recommend Favorite

Modelling Anxiety in Humans for Drug Development

Current Neuropharmacology, Vol. 5, Iss. 1, 2007-03 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite